"Our Port Washington Rd Cancer Care clinic offers advanced cancer care services, and is conveniently located within Aurora Medical Center Grafton."

During the past decade, Aurora Cancer Care-Grafton conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 60 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 57 clinical trials were completed. i.e. 103.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora Cancer Care-Grafton" #1 sponsor was "National Cancer Institute (NCI)" with 74 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "NRG Oncology" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Cancer Care-Grafton" #1 collaborator was "National Cancer Institute (NCI)" with 99 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Aurora Cancer Care-Grafton" are "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Aurora Cancer Care-Grafton" in a lesser frequency.

Most popular intervention types in "Aurora Cancer Care-Grafton" are "Drug" (136 trials), "Other" (115 trials), "Biological" (61 trials), "Procedure" (51 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (59 trials), "Laboratory Biomarker Analysis" (49 trials), "Questionnaire Administration" (35 trials), "Computed Tomography" (24 trials) and "Biospecimen Collection" (21 trials). Other intervention names were less common.

The vast majority of trials in "Aurora Cancer Care-Grafton" are 130 trials for "All" genders, 37 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Aurora Cancer Care-Grafton". undefined are not yet recruiting, 50 are recruiting, 93 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Aurora Cancer Care-Grafton, 6 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora Cancer Care-Grafton, 3 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".